Erythropoiesis and the mystery of an unexplained survival benefit.
Velmahos
George C
GC
D001930:Brain Injuries / Q000097:blood / Q000188:drug therapy* / Q000401:mortality; D000068256:Darbepoetin alfa; D004921:Erythropoietin / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D006397:Hematinics / Q000008:administration & dosage*; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D007279:Injections, Subcutaneous; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011994:Recombinant Proteins; D015996:Survival Rate
D006397:Hematinics; D006454:Hemoglobins; D018696:Neuroprotective Agents; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa